Evidence map›Paper›PMID 30866561›Full record

ArticleMolecules (Basel, Switzerland)2019

Optimization and Formulation of Fucoxanthin-Loaded Microsphere (F-LM) Using Response Surface Methodology (RSM) and Analysis of Its Fucoxanthin Release Profile.

Irwandi Jaswir, Dedi Noviendri, Muhammad Taher, Farahidah Mohamed, Fitri Octavianti, Widya Lestari, Ali Ghufron Mukti, Sapta Nirwandar, Bubaker B Hamad Almansori

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pharmaceutics · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Irwandi JaswirInternational Institute for Halal Research and Training (INHART), International Islamic University Malaysia, Jalan Gombak, Kuala Lumpur 53100, Malaysia. irwandi@iium.edu.my.
Dedi NoviendriBioprocess and Molecular Engineering Research Unit (BPMERU), International Islamic University Malaysia (IIUM) Gombak, Kuala Lumpur 53100, Malaysia. ir98@hotmail.com.
Muhammad TaherDepartment of Pharmaceutical Technology, Faculty of Pharmacy, International Islamic University Malaysia Kuantan, Kuantan 25200, Malaysia. mtaher@iium.edu.my.
Farahidah MohamedDepartment of Pharmaceutical Technology, Faculty of Pharmacy, International Islamic University Malaysia Kuantan, Kuantan 25200, Malaysia. farahidah@iium.edu.my.ORCID 0000-0003-3971-1443
Fitri OctaviantiDepartment of Orthodontics, Faculty of Dentistry, Universiti Sains Islam Malaysia, Tower B, Persiaran MPAJ, Jalan Pandan Utama, Kuala Lumpur 55100, Malaysia. yanti75@yahoo.com.
Widya LestariInternational Institute for Halal Research and Training (INHART), International Islamic University Malaysia, Jalan Gombak, Kuala Lumpur 53100, Malaysia. dokterwidya@gmail.com.
Ali Ghufron MuktiMinistry of Research, Technology and Higher Education of Indonesia, Senayan, Jakarta Pusat 10340, Indonesia. ghufronmukti@yahoo.com.
Sapta NirwandarChairman, Indonesia Halal Lifestyle Foundation, Jakarta 10230, Indonesia. bob.naedi@gmail.com.
Bubaker B Hamad AlmansoriInternational Institute for Halal Research and Training (INHART), International Islamic University Malaysia, Jalan Gombak, Kuala Lumpur 53100, Malaysia. science.abu@gmail.com.

Funding

Ministry of Higher Education, Malaysia MOHE 18-002-0002.
6 · The paper itself

Abstract

Fucoxanthin has interesting anticancer activity, but is insoluble in water, hindering its use as a drug. Microencapsulation is used as a technique for improving drug delivery. This study aimed to formulate fucoxanthin-loaded microspheres (F-LM) for anticancer treatment of H1299 cancer cell lines and optimize particle size (PS) and encapsulation efficiency (EE). Using response surface methodology (RSM), a face centered central composite design (FCCCD) was designed with three factors: Polyvinylalcohol (PVA), poly(d,l-lactic-co-glycolic acid) (PLGA), and fucoxanthin concentration. F-LM was produced using a modified double-emulsion solvent evaporation method. The F-LM were characterized for release profile, release kinetics, and degradation pattern. Optimal F-LM PS and EE of 9.18 µm and 33.09%, respectively, with good surface morphology, were achieved from a 0.5% (

Indexed as

Antineoplastic AgentsCell Line, TumorDrug CompoundingHumansMicrospheresParticle SizeSolubilityXanthophyllsAntineoplastic AgentsfucoxanthinXanthophyllsfucoxanthinmicroencapsulationmicrosphererelease profileresponse surface methodology

Identifiers

PMID30866561
PMCPMC6429396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.